Concepedia

Yoshiaki Okubo

YO

Statistics

Publications

21

Citations

968

H-Index

15

Active since

1997

Affiliations

Keio University(Current)

Massachusetts General Hospital

Harvard University

Hokkaido University

Keio University Hospital

Yoshiaki Okubo is an author at Keio University specializing in immunology, life sciences, and type 1 diabetes pathophysiology.

Publications per year

1997–2020

21

Publications

21

Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated T <sub>regs</sub>

Heather Torrey, John Butterworth, Toshiyuki Mera et al. · Science Signaling · 2017 · 182 citations

, , +17

Homogeneous Expansion of Human T-Regulatory Cells Via Tumor Necrosis Factor Receptor 2

Yoshiaki Okubo, Toshiyuki Mera, Limei Wang et al. · Scientific Reports · 2013 · 169 citations · Full text

, , +10

Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes

Denise L. Faustman, Limei Wang, Yoshiaki Okubo et al. · PLoS ONE · 2012 · 167 citations · Full text

, , +17

Treg activation defect in type 1 diabetes: correction with TNFR2 agonism

Yoshiaki Okubo, Heather Torrey, John Butterworth et al. · Clinical & Translational Immunology · 2016 · 108 citations · Full text

, , +16

A novel TNFR2 agonist antibody expands highly potent regulatory T cells

Heather Torrey, Willem M. Kühtreiber, Yoshiaki Okubo et al. · Science Signaling · 2020 · 60 citations

, , +16

1–5 of 21